– MARIO-4, the first eganelisib registration-enabling trial, in front-line metastatic triple negative breast cancer expected to initiate by the end of 2022 – – MARIO-P, a study designed to expand ...

There’s perhaps never been a better time to be an office broker in South Florida. While industry leaders fretted over the future of the office in the wake of the pandemic, South Florida brokers didn’t ...

Infinity Pharmaceuticals (INFI) got off to a market-beating start this week as its shares zoomed 3.8% higher Monday, on the back of new analyst coverage that made an extremely bullish case for ...

WINDSOR, CT, USA, February 7, 2023 /EINPresswire.com/ -- Infinity™ Fuel Cell and Hydrogen, Inc. today announced the recent signing of the first commercial contract ...

WINDSOR, Conn.--(BUSINESS WIRE)--Infinity Fuel Cell and Hydrogen, Inc. today revealed that it is actively exploring new markets for its air-independent non-flow-through hydrogen fuel cells in the ...